Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 311

1.

Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.

Inan S, Eisenstein TK, Watson MN, Doura M, Meissler JJ, Tallarida CS, Chen X, Geller EB, Rawls SM, Cowan A, Adler MW.

J Pharmacol Exp Ther. 2018 Dec;367(3):433-441. doi: 10.1124/jpet.118.252890. Epub 2018 Sep 24.

PMID:
30249618
2.

Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.

Wang X, Ma TC, Li JL, Zhou Y, Geller EB, Adler MW, Peng JS, Zhou W, Zhou DJ, Ho WZ.

Front Microbiol. 2015 Nov 4;6:1230. doi: 10.3389/fmicb.2015.01230. eCollection 2015.

3.

A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10.

Robinson RH, Meissler JJ, Fan X, Yu D, Adler MW, Eisenstein TK.

J Neuroimmune Pharmacol. 2015 Jun;10(2):318-32. doi: 10.1007/s11481-015-9611-3. Epub 2015 May 16.

4.

Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.

Robinson RH, Meissler JJ, Breslow-Deckman JM, Gaughan J, Adler MW, Eisenstein TK.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1239-50. doi: 10.1007/s11481-013-9485-1. Epub 2013 Jul 4.

5.

Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons.

Brailoiu GC, Deliu E, Hooper R, Dun NJ, Undieh AS, Adler MW, Benamar K, Brailoiu E.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):277-81. doi: 10.1016/j.drugalcdep.2011.11.021. Epub 2011 Dec 21.

6.

Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection.

Breslow JM, Monroy MA, Daly JM, Meissler JJ, Gaughan J, Adler MW, Eisenstein TK.

J Neuroimmune Pharmacol. 2011 Dec;6(4):551-65. doi: 10.1007/s11481-011-9303-6. Epub 2011 Aug 9.

7.

Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120.

Palma J, Cowan A, Geller EB, Adler MW, Benamar K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):497-9. doi: 10.1016/j.drugalcdep.2011.04.010. Epub 2011 May 19.

8.

The effect of gp120 on morphine's antinociceptive and neurophysiological actions.

Chen X, Kirby LG, Palma J, Benamar K, Geller EB, Eisenstein TK, Adler MW.

Brain Behav Immun. 2011 Oct;25(7):1434-43. doi: 10.1016/j.bbi.2011.04.014. Epub 2011 May 5.

9.

Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain.

Benamar K, Palma J, Cowan A, Geller EB, Adler MW.

Drug Alcohol Depend. 2011 Apr 1;114(2-3):246-8. doi: 10.1016/j.drugalcdep.2010.08.015. Epub 2010 Nov 26.

10.

Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.

Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, Adler MW, Seltzman HH, Reggio PH, Heynen-Genel S, Sauer M, Chung TD, Bai Y, Chen W, Caron MG, Barak LS, Abood ME.

Mol Pharmacol. 2010 Oct;78(4):560-8. doi: 10.1124/mol.110.066746. Epub 2010 Jul 22.

11.

Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent.

Breslow JM, Feng P, Meissler JJ, Pintar JE, Gaughan J, Adler MW, Eisenstein TK.

Microb Pathog. 2010 Dec;49(6):330-5. doi: 10.1016/j.micpath.2010.07.006. Epub 2010 Aug 3.

12.

Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.

Anton B, Leff P, Meissler JJ, Calva JC, Acevedo R, Salazar A, Matus M, Flores A, Martinez M, Adler MW, Gaughan JP, Eisenstein TK.

J Neuroimmune Pharmacol. 2010 Mar;5(1):143-54. doi: 10.1007/s11481-010-9190-2. Epub 2010 Feb 2.

13.

Intrahypothalamic injection of the HIV-1 envelope glycoprotein induces fever via interaction with the chemokine system.

Benamar K, Addou S, Yondorf M, Geller EB, Eisenstein TK, Adler MW.

J Pharmacol Exp Ther. 2010 Feb;332(2):549-53. doi: 10.1124/jpet.109.160309. Epub 2009 Nov 11.

14.

Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.

Benamar K, Yondorf M, Geller EB, Eisenstein TK, Adler MW.

Br J Pharmacol. 2009 Aug;157(7):1225-31. doi: 10.1111/j.1476-5381.2009.00285.x. Epub 2009 Jun 22.

15.

CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.

Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF.

Microvasc Res. 2009 Jun;78(1):86-94. doi: 10.1016/j.mvr.2009.03.005. Epub 2009 Mar 28.

16.

Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.

Zhang M, Martin BR, Adler MW, Razdan RJ, Kong W, Ganea D, Tuma RF.

J Neuroimmune Pharmacol. 2009 Jun;4(2):249-59. doi: 10.1007/s11481-009-9148-4. Epub 2009 Mar 3. Review.

17.

A new brain area affected by 3,4-methylenedioxymethamphetamine: A microdialysis-biotelemetry study.

Benamar K, Geller EB, Adler MW.

Eur J Pharmacol. 2008 Oct 31;596(1-3):84-8. doi: 10.1016/j.ejphar.2008.08.001. Epub 2008 Aug 13.

PMID:
18727928
18.

Elevated level of the proinflammatory chemokine, RANTES/CCL5, in the periaqueductal grey causes hyperalgesia in rats.

Benamar K, Geller EB, Adler MW.

Eur J Pharmacol. 2008 Sep 11;592(1-3):93-5. doi: 10.1016/j.ejphar.2008.07.009. Epub 2008 Jul 11.

PMID:
18656466
19.

Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor.

Finley MJ, Chen X, Bardi G, Davey P, Geller EB, Zhang L, Adler MW, Rogers TJ.

J Neuroimmunol. 2008 Jul 15;197(2):114-23. doi: 10.1016/j.jneuroim.2008.04.021. Epub 2008 Jun 3.

20.

Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity.

Anton B, Leff P, Calva JC, Acevedo R, Salazar A, Matus M, Pavón L, Martinez M, Meissler JJ, Adler MW, Gaughan JP, Eisenstein TK.

Brain Behav Immun. 2008 Aug;22(6):824-32. doi: 10.1016/j.bbi.2008.02.004. Epub 2008 Apr 18.

21.

Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.

Zhang M, Martin BR, Adler MW, Razdan RK, Ganea D, Tuma RF.

Neuroscience. 2008 Mar 27;152(3):753-60. doi: 10.1016/j.neuroscience.2008.01.022. Epub 2008 Jan 25.

22.

First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.

Benamar K, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2008 May;325(2):641-5. doi: 10.1124/jpet.107.135053. Epub 2008 Feb 15. Erratum in: J Pharmacol Exp Ther. 2008 Jun;325(3):1061.

23.

Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury.

Baty DE, Zhang M, Li H, Erb CJ, Adler MW, Ganea D, Loftus CM, Jallo JI, Tuma RF.

Clin Neurosurg. 2008;55:172-7. No abstract available.

PMID:
19248685
24.

Deletion of mu-opioid receptor in mice alters the development of acute neuroinflammation.

Benamar K, Yondorf M, Barreto VT, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2007 Dec;323(3):990-4. Epub 2007 Sep 26.

25.

Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.

Eisenstein TK, Meissler JJ, Wilson Q, Gaughan JP, Adler MW.

J Neuroimmunol. 2007 Sep;189(1-2):17-22. Epub 2007 Jul 19.

26.
27.

Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model.

Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF.

J Cereb Blood Flow Metab. 2007 Jul;27(7):1387-96. Epub 2007 Jan 24.

28.

A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.

Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK, Adler MW.

J Pharmacol Exp Ther. 2007 Mar;320(3):1127-33. Epub 2006 Dec 28.

29.
30.

Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.

Chen X, Geller EB, Rogers TJ, Adler MW.

Drug Alcohol Depend. 2007 Apr 17;88(1):36-41. Epub 2006 Oct 17.

31.
32.

Viewing chemokines as a third major system of communication in the brain.

Adler MW, Geller EB, Chen X, Rogers TJ.

AAPS J. 2006 Jan 6;7(4):E865-70. Review.

33.

Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.

Feng P, Rahim RT, Cowan A, Liu-Chen LY, Peng X, Gaughan J, Meissler JJ Jr, Adler MW, Eisenstein TK.

Eur J Pharmacol. 2006 Mar 18;534(1-3):250-7. Epub 2006 Mar 2.

PMID:
16513108
34.
35.

The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.

Chen X, McClatchy DB, Geller EB, Tallarida RJ, Adler MW.

Life Sci. 2005 Dec 12;78(4):329-33. Epub 2005 Oct 28.

PMID:
16257420
36.

Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine.

Rahim RT, Meissler JJ Jr, Adler MW, Eisenstein TK.

J Leukoc Biol. 2005 Dec;78(6):1185-91. Epub 2005 Oct 4.

PMID:
16204646
37.

Are chemokines the third major system in the brain?

Adler MW, Rogers TJ.

J Leukoc Biol. 2005 Dec;78(6):1204-9. Epub 2005 Oct 4. Review.

PMID:
16204637
38.

Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12.

Feng P, Meissler JJ Jr, Adler MW, Eisenstein TK.

J Neuroimmunol. 2005 Jul;164(1-2):57-65.

PMID:
15913793
39.

Unresponsiveness of mu-opioid receptor knockout mice to lipopolysaccharide-induced fever.

Benamar K, McMenamin M, Geller EB, Chung YG, Pintar JE, Adler MW.

Br J Pharmacol. 2005 Apr;144(8):1029-31.

40.

Intrahypothalamic injection of deltorphin-II alters body temperature in rats.

Benamar K, Rawls SM, Geller EB, Adler MW.

Brain Res. 2004 Sep 3;1019(1-2):22-7.

PMID:
15306234
41.

GABAA receptors modulate cannabinoid-evoked hypothermia.

Rawls SM, Tallarida RJ, Kon DA, Geller EB, Adler MW.

Pharmacol Biochem Behav. 2004 May;78(1):83-91.

PMID:
15159137
42.

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.

Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF.

Mult Scler. 2004 Apr;10(2):158-64.

PMID:
15124761
43.

Paradoxes of immunosuppression in mouse models of withdrawal.

Rahim RT, Feng P, Meissler JJ, Rogers TJ, Zhang L, Adler MW, Eisenstein TK.

J Neuroimmunol. 2004 Feb;147(1-2):114-20.

PMID:
14741440
45.

Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules.

Rahim RT, Meissler JJ, Zhang L, Adler MW, Rogers TJ, Eisenstein TK.

J Neuroimmunol. 2003 Nov;144(1-2):16-27.

PMID:
14597094
46.

Role of the nitric-oxide synthase isoforms during morphine-induced hyperthermia in rats.

Benamar K, Yondorf MZ, Kon D, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2003 Oct;307(1):219-22. Epub 2003 Sep 3.

47.

NMDA receptors modulate morphine-induced hyperthermia.

Rawls SM, Adler MW, Gaughan JP, Baron A, Geller EB, Cowan A.

Brain Res. 2003 Sep 12;984(1-2):76-83.

PMID:
12932841
48.

A survey of STI policies and programmes in Europe.

Adler MW.

Sex Transm Infect. 2003 Apr;79(2):171. No abstract available.

49.

Sexual health--health of the nation.

Adler MW.

Sex Transm Infect. 2003 Apr;79(2):85-7. No abstract available.

Supplemental Content

Loading ...
Support Center